Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?

For over 40 years the standard treatment for acute myeloid leukemia (AML) patients has been a combination of chemotherapy consisting of cytarabine and an anthracycline such as daunorubicin. This standard treatment results in complete remission (CR) in the majority of AML patients. However, despite t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martiáñez Canales, Tania, de Leeuw, David C., Vermue, Eline, Ossenkoppele, Gert J., Smit, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532610/
https://www.ncbi.nlm.nih.gov/pubmed/28665351
http://dx.doi.org/10.3390/cancers9070074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532610/
https://www.ncbi.nlm.nih.gov/pubmed/28665351
http://dx.doi.org/10.3390/cancers9070074

Ejemplares similares